Results for “THC VENTURE III LLC”

…et specific health conditions or otherwise cause an intended, desirable effect on users. Cannabis strains with specific THC to CBD ratios are currently the predominant focus for therapeutic applications. THC to CBD ratios in strains popular for treating certain medical conditions...

…tent 27,475), cannabis cultivation and processing methods (U.S. Patent 9,095,554), a vaporizer (U.S. Patent 9,220,294), THC-infused shea butter for topical application (U.S. Patent 8,425,954), a THC extraction method (U.S. Patent 6,365,416) and equipment and methods for biosynthe...

… on cannabinoid receptors in cells in the human nervous and immune systems Cannabinol (CBN) a cannabinoid derived from THC degradation; shown to produce some psycho- active effects and believed to have several medicinal benefits, including analgesic, antibacterial, anticonvulsiv...

…he company develops pre-filled cannabis vaporizers, car- tridges and wax that offer the consumer formu- lations of both THC and CBD. The company’s products are available in dispensaries through- out California. © 2017 Ackrell Capital, LLC | Member FINRA/SIPC CHAPTER VIII Top 10...

…edical Cannabis Laws More States Adopt Recreational Laws 15% FDA Routinely Approves CBD Drugs FDA Routinely Approves THC Drugs 10% — Federal Government Legalizes Cannabis 5% - 0% - 2016 «2017 «2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 Source: Ackrell...

Filer’s Name a Donald J. Trump Part 2: Filer's Employment Assets and Income |Description EIF |attached schedule Income Amount | (Part 2 - BIT A) ; Reference # TRUMP TOWER MANAGING MEMBER INC. WA 1445 $1,001 - $15,000 None (or less than $201) Value reported reflects bank accoun...

of which Mr. Garcia III is the sole beneficiary. While Ernest Garcia II and Ernest Garcia III are the

NLV-III Investment Opportunity The objective of NLV-III is to invest in a portfolio of healthcare technology companies that offer attractive risk-adjusted returns. The companies that comprise the portfolio will be selected and managed by a team of highly experienced senior partn...

LAFFER ASSOCIATES Supply-Side Investment Research May 19, 2016 10-yr T-Note: 1.86% DJIA: 17,526.62 NASDAQ: 4,739.12 S&P 500: 2,047.63 S&P 500 Undervalued: 151.8% GAME ON [Updated 7/6/2016] By Arthur B. Laffer, Ph.D. Summary To save you the agony of plodding through this fascinat...

you I and Brad karp sit together if you think it would be helpful. . I would like to send him this email, with your consent of course. Ifthe transactions were never consummated , 1 would not be owed a dime, however , the expected fee was known up front. , the detailed step by ste...

…ivate and public opportunities. The established and proven sourcing activities seek to identify the most compelling healthcare technology investment opportunities, at the most attractive time points for venture capital investment. The Fund Managers’ goal is to identify opportunit...

From: Steven Victor MD 111.11111..... Sent: 11/23/2012 1:06:38 PM To: CC: Subject: Report on Stem Cells future PUBLISHED: 22 NOVEMBER 2012 The view from the US: Stem cell therapy steps up a gear with first approval and improved political climate Special Report Peter Winter Positi...

… (acquired by Abbott), PercuSurge (acquired by Medtronic), and NxStage Medical (NASDAQ: NXTM). Prior to joining the healthcare investment team at Sprout, Jeani was a General Partner at Weiss, Peck & Greer Venture Partners (“WPGVP”) where she focused on healthcare investments. Bef...

…e networks of deal sources that have been built and cultivated over two decades and focus on identifying compelling healthcare technology investment opportunities, at attractive time points for investment. These efforts balance the inherent attractiveness of an innovative technol...

James Niedel, MD, Ph.D., (70), Venture Partner, joined Sprout in May 2002 and helped found New Leaf in 2005. Jim will change his status to Venture Partner in NLV-II] with the closing of the new fund. In this role, Jim will work full-time as a senior member of the NLV investment t...